CENTRAL EFFECT OF BOTULINUM TOXIN TYPE A IN HUMANS

REFERENCES

• Abbruzzese G., Buccolieri A., Marchese R., Trompetto C., Mandich P., Schieppati M. Intracortical inhibition and facilitation are abnormal in Huntington's disease: A paired magnetic stimulation study. Neuroscience Letters 1997; 228: 87–90, [INFOTRIEVE], [CSA]
   Google Scholar
• Bertasi V., Bertolasi L., Frasson E., Priori A. The excitability of human cortical inhibitory circuits responsible for the muscle silent period after transcranial brain stimulation. Experimental Brain Research 2000; 132: 384–389, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Black J. D., Dolly J. O. Selective location of acceptors for botulinum neurotoxin A in the central and peripheral nervous system. Neuroscience 1987; 23: 767–769, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Boroff D. A., Chen G. S. On the question of permeability of the blood-brain barrier to BTA. Brain 1997; 120: 409–416, [CSA], [CROSSREF]
   Google Scholar
• Boroojerdi B., Cohen L. G., Hallett M. Effects of botulinum toxin on motor system excitability in patients with writer's cramp. Neurology 2003; 61: 1546–1550, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Brashear A., Lew M. F., Dykstra D. D., Comella C. L., Factor S. A., Rodnitzky R. L., Trosch R., Singer C., Brin M. F., Murray J. J., Wallace J. D., Willmer-Hulme A., Koller M. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology 1999; 53: 1439–1446, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Brin M. F. Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology. Muscle & Nerve. Supplement 1997; 6: S146–S168, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Cantello R., Gianelli M., Civardi C., Mutani R. Magnetic brain stimulation: The silent period after the motor evoked potential. Neurology 1992; 42: 1951–1959, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Cheshire W. P., Abashian S. W., Mann J. D. Botulinum toxin in the treatment of myofascial pain syndrome. Pain 1994; 59: 65–69, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Curra A., Trompetto C, Abbruzzese G., Berardelli A. Central effects of botulinum toxin type A: Evidence and supposition. Movement Disorders 2004; 19: S60–S64, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• DasGupta B. R., Tepp W. Protease activity of botulinum neurotoxin type E and its light chain: Cleavage of actin. Biochimical and Biophysical Research Communications 1993; 190: 470–474, [CSA], [CROSSREF]
   Google Scholar
• Davey N. J., Romaiguere P., Maskill D. W., Ellaway P. H. Suppression of voluntary motor activity revealed using transcranial magnetic stimulation on the motor cortex. Journal of Physiology 1994; 477: 223–235, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Fehlings D., Rang M., Glazier J., Steele C. An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. The Journal of Pediatrics 2000; 137: 331–337, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Freund B. J., Schwartz M. Treatment of chronic cervical-associated headache with botulinum toxin A: A pilot study. Headache 2000; 40: 231–236, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Garner C. G., Straube A., Witt T. N., Oertel W. H. Time course of distant effects of local injections of botulinum toxin. Movement Disorders 1993; 8: 33–37, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gilio F., Curra A., Lorenzano C., Modugno N., Manfredi M., Berardelli A. Effects of Botulinum toxin type A on intracortical inhibition in patients with dystonia. Annals of Neurology 2000; 48: 20–26, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gundersen C. B. The effects of botulinum toxin on the synthesis, storage and release of acetylcholine. Progress in Neurobiology 1980; 14: 99–119, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Habermann E. 125-I labeled neurotoxin from Clostridium Botulinum A: A preparation, binding to synaptosomes and ascent to spinal cord. Naunyn-Schmiedeberg's Archives of Pharmacology 1974; 281: 47–56, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Hagenah R., Benecke R., Wiegand H. Effects of type A Botulinum toxin on the cholinergic transmission at the spinal Renshaw cells and on the inhibitory action at Ia inhibitory interneurones. Archives of Pharmacology 1977; 299: 267–272, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ishikawa H., Mitsui Y., Yoshitomi T., Mashimo K., Aoki S., Mukuno K., Shimizu K. Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles. Japanese Journal of Ophthalmology 2000; 44: 106–109, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kohda T., Kamata Y., Kozaki S. Endocytosis of Clostridium botulinum type B neurotoxin into rat brain synaptosomes. The Journal of Veterinary Medical Science 2000; 62: 1133–1138, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Kujirai T., Caramia M. D., Rothwell J. C., Day B. L., Thompson P. D., Ferbert A., Wroe S., Asselman P., Marsden C. D. Corticocortical inhibition in human motor cortex. Journal of Physiology 1993; 471: 501–519, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Mills K. R., Boniface S. J., Schubert M. Origin of the secondary increase in firing probability of human motoneurons following transcranial magnetic stimulation. Studies in healthy subjects, type I hereditary motor and sensory neuropathy and multiple sclerosis. Brain 1991; 114: 2451–2463, [INFOTRIEVE], [CSA]
   Google Scholar
• Rosales R. L., Arimura K., Takenaga S., Osame M. Extrafusal and intrafusal muscle effects in experimental Botulinum toxin-A injection. Muscle & Nerve 1996; 19: 488–496, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rossini P. M., Barker A. T., Berardelli A., Caramia M. D., Caruso G., Cracco R. Q., Dimitrijevic M. R., Hallett M., Katayama Y., Lucking C. H., Maertens de Noordhout A. L., Marsden C. D., Murray N. M. F., Rothwell J. C., Swash M., Tomberg C. Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: Basic principles and procedures for routine clinical application. Report of an IFNC committee. Electroencephalograph and Clinical Neurophysiology 1994; 91: 79–92, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Scott A. B. Botulinum toxin injection of eye muscles to correct strabismus. Transactions of the American Ophthalmological Society 1981; 79: 734–770, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Scott A. B., Kennedy R. A., Stubbs H. A. Botulinum toxin injection as a treatment for blepharospasm. Archives of Ophthalmology 1985; 103: 347–350, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Simpson D. M., Alexander D. N., O'Brien C. F., Tagliati M., Aswad A. S., Leon J. M., Gibson J., Mordaunt J. M., Monaghan E. P. Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial. Neurology 1996; 46: 1306–1310, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Sloop R. R., Escutin R. O., Matus J. A., Cole B. A., Peterson G. W. Dose-response curve of human extensor digitorium brevis muscle function to intramuscular injected botulinum toxin type A. Neurology 1995; 46: 1382–1386, [CSA]
   Google Scholar
• Triggs W. J., Cros D., Fang J., Chiappa K. H. Facilitation of magnetic motor evoked potentials during the cortical stimulation silent period. Neurology 1993; 43: 2615–2620, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Wiegand H., Erdmann G., Wellhoner H. H. 123I-labeled botulinum A neurotoxin: Pharmacokinetics in cats after intramuscular injection. Naunyn-Schmiedeberg's Archives of Pharmacology 1976; 292: 161–165, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ziemann U., Rothwell J. C., Ridding M. C. Interaction between intracortical and facilitation in human motor cortex. Journal of Physiology 1996; 496: 873–881, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar